FIELD: medicine, immunology, vaccines. SUBSTANCE: vaccine has polysaccharide conjugated with protein. Indicated protein and polysaccharide are typical molecules of streptococcus of group B. The used protein is recombinant one S1 and it is encoded by plasmid pJMSI ATCC N 40659. Vaccine induces T-independent immunity against infection caused by streptococcus of group B. Vaccine is able to produce immunity in recipient against infection caused by streptococcus of group B. EFFECT: enhanced effectiveness of vaccine. 8 cl, 6 dwg , 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT DNA MOLECULE ENCODING PROTEIN OF ALPHA-ANTIGEN OF STREPTOCOCCUS GROUP B, PLASMID VECTOR | 1993 |
|
RU2209247C2 |
| METHODS AND COMPOSITIONS DESCRIBED AS SYNTHETIC BETA-1,6-GLUCOSAMINOLIGOSACCHARIDES | 2009 |
|
RU2532911C2 |
| LIVE VACCINE BASED ON ENTEROCOCCUS FAECIUM L3 PROBIOTIC STRAIN FOR PREVENTION OF INFECTION CAUSED BY STREPTOCOCCUS PNEUMONIE | 2018 |
|
RU2701733C1 |
| HYBRID PROTEIN VACCINE AGAINST PNEUMONIA CAUSED BY Streptococcus pneumoniae | 2012 |
|
RU2510281C2 |
| COMPLEX OF RECOMBINANT POLYPEPTIDES WITH PROTECTIVE PROPERTIES IN RELATION TO STREPTOCOCCUS AGALACTIAE AND STREPTOCOCCUS PYOGENES | 2014 |
|
RU2587627C2 |
| PROTEIN CHIMERIC RECEPTOR, DNA ENCODING PROTEIN CHIMERIC RECEPTOR | 1994 |
|
RU2158305C2 |
| METHOD FOR INTROGRESSION OF PATHOGENIC STREPTOCOCCUS GENES IN CHROMOSOMAL DNA OF PROBIOTIC STRAIN OF ENTEROCOCCUS FAECIUM L3 FOR EXPRESSION IN PILES | 2015 |
|
RU2640250C2 |
| HERPETIC FEVER VIRUS VACCINES | 2010 |
|
RU2575067C2 |
| METHOD OF DIRECTION OF IMMUNE RESPONSE INDUCTION, DNA, VECTOR, METHOD OF TREATMENT | 1992 |
|
RU2161044C2 |
| VACCINES WITH APPLICATION OF VESICLES BASED ON GNA 1870 OF BROAD SPECTRUM OF ACTION FOR PREVENTION OF DISEASES, CAUSED BY NEISSERIA MENINGITIDIS | 2006 |
|
RU2432962C2 |
